New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill AJR92

Introduced
1/9/24  

Caption

Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

Impact

The resolution is significant as it addresses a critical public health issue, advocating for heightened awareness regarding the challenges faced by those living with rare diseases. These challenges include isolation, obtaining timely diagnoses, and accessing appropriate treatment options. By designating a specific day for awareness, the resolution aims to draw attention to the needs of nearly one in ten Americans who are affected by these conditions and may not have adequate resources or support.

Summary

AJR92 is a joint resolution introduced in New Jersey's 221st Legislature that designates the last day of February each year as 'Rare Disease Awareness Day.' This initiative aims to raise public awareness about rare diseases and promote support for those affected, as well as encourage further research into potential treatments for these conditions. According to the National Institutes of Health, a rare disease is defined as one that affects fewer than 200,000 persons in the U.S., with nearly 30 million Americans impacted by various rare diseases, including conditions like cystic fibrosis and muscular dystrophy.

Contention

While the resolution is largely supportive, there may be contention regarding the effectiveness of awareness days in generating actual change or funding for research. Critics might argue that merely raising awareness doesn't directly translate into improvements for patients or increased funding for research. Nonetheless, proponents believe that increased visibility can lead to better advocacy for policies that support research funding and treatment access, which are crucial for those affected by rare diseases.

Companion Bills

NJ SJR74

Same As Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

NJ SJR104

Carry Over Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

NJ AJR227

Carry Over Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

Previously Filed As

NJ AJR114

Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

NJ SJR88

Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

NJ AJR19

Designates May 7 of each year as "Cystinosis Awareness Day" in New Jersey.

NJ AJR141

Designates March 1 of each year as "Endometriosis Awareness Day" in New Jersey.

NJ SJR27

Permanently designates last week in February as "Eating Disorders Awareness Week" in New Jersey.

NJ AJR14

Designates October 1 of each year as "New Jersey Diner Day".

NJ AJR160

Designates May 30 of each year as "Stigma Free Awareness Day" in NJ.

NJ SJR30

Designates October of each year as "Eczema Awareness Month" in New Jersey.

NJ AJR139

Designates month of September each year as "Deaf Awareness Month" in New Jersey; designates last full week of September each year as "Deaf Awareness Week" in New Jersey.

NJ AJR185

Designates May of each year as "Asthma and Allergy Awareness Month" in New Jersey.

Similar Bills

WI AB925

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

AZ HB2944

Inpatient treatment days; computation; exclusion

CA AB1879

Substance use: treatment or residential data reporting.

WI SB904

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

CA AB2538

Medi-Cal: hospice providers: forms.

AZ SB1244

court-ordered treatment; continuation

IA HF518

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)

IA HF326

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)